Find out about many of our previous research studies and trials, and those that are ongoing but are no longer recruiting participants.
Fish Oil Trial The use of fish oil supplements as part of daily dietary intake is very common among children with an autism spectrum disorder (ASD). Some evidence suggests that omega-3 fatty acids found in fish oil are important for brain development and may be of significant benefit to children with ASD.
The Oxytocin Trial The Oxytocin Trial is a multisite randomized controlled trial that aims to determine the efficacy of a novel biological intervention, oxytocin (OT) nasal spray, as a treatment for impaired social functioning in young children with Autism Spectrum Disorder (ASD) aged 3-6 years.
Fluoxetine for Autistic Behaviours (FAB) trial Fluoxetine belongs to a class of medications known as the Selective Serotonin Reuptake Inhibitors (SSRIs) which are thought to help in treating repetitive behaviours. It is therefore important for us to know that Fluoxetine is effective in treating repetitive behaviours in children with autism.
The TOBY trial The TOBY trial is a multisite randomized controlled trial that looks at determining the effectiveness of the TOBY (Therapy Outcomes By You) Playpad application (app) as a complement to existing therapy and to examine the attitudes and beliefs of parents towards the TOBY app as an intervention method.
Raine Study The Raine Study is an ongoing health research project. From 1989 through to 1991, 2900 mothers enrolled during their pregnancy. Over the past twenty years they, and their children, have remained involved in the project.
Autism and Language Impairment It has been suggested that autism and developmental language disorder may share similar causes. We want to find out whether children with autism and children with SLI show some of the same thinking styles.